Pediatric thrombocytopenia is a condition in which a child has low platelet counts (below the normal range of 150,000 to 450,000 platelets per microliter of blood). Platelets are blood cells responsible for blood clotting and wound healing. When platelet levels drop too low, it can lead to excessive bleeding and difficulty forming blood clots.
Thrombocytopenia can occur due to various underlying conditions, ranging from transient viral infections to serious bone marrow disorders. In many cases, pediatric thrombocytopenia is mild and self-limiting, but in some situations, it can require urgent medical intervention.
Thrombocytopenia in children refers to a platelet count below 150,000 platelets per microliter of blood. It may arise due to various causes, from infections and medications to immune system disorders and bone marrow diseases. While some cases are mild and temporary, others may require medical intervention.
Early diagnosis and tailored treatment are crucial for preventing complications and supporting healthy development.
The causes of thrombocytopenia in children can be grouped into several categories:
Diagnosis involves a combination of physical examination, blood tests, and sometimes bone marrow evaluation. Common diagnostic tools include:
Pediatric hematologists like Dr. Rahul Bhargava, who heads the Hematology & BMT Department at Fortis Hospital Gurgaon, specialize in accurately diagnosing and managing these conditions.
Treatment varies based on the underlying cause and severity of the condition. In mild cases, monitoring may be enough. In more serious cases, medical or surgical interventions may be necessary.
Mild cases of ITP often resolve on their own, especially in younger children.
Used in emergencies or for severe bleeding.
In cases involving bone marrow failure or inherited marrow disorders, BMT may be a curative option. Dr. Rahul Bhargava is among the pioneers of pediatric BMT in India and has extensive experience treating such cases.
Rarely used in children unless all other treatments fail.
India offers cost-effective care without compromising quality. The overall cost varies depending on the cause, treatment approach, hospital stay, and whether a bone marrow transplant is required.
| Treatment Type | Estimated Cost (USD) |
|---|---|
| Initial Consultation & Tests | $100 – $300 |
| IVIG or Steroid Therapy | $500 – $1,500 per cycle |
| Platelet Transfusions | $200 – $400 per unit |
| Bone Marrow Transplant | $18,000 – $30,000 |
India’s affordability makes it a preferred destination for families seeking specialized pediatric care.
Dr. Rahul Bhargava is one of India’s leading hematologists and bone marrow transplant specialists. He currently serves as the Director of Hematology and BMT at Fortis Memorial Research Institute, Gurugram. With decades of experience, Dr. Bhargava has performed hundreds of successful bone marrow transplants in children and is well-regarded for his expertise in managing pediatric blood disorders.
His compassionate approach, commitment to global treatment protocols, and dedication to improving pediatric hematology outcomes make him a trusted name for families across India and abroad.
Parents from across the globe have traveled to India to seek treatment under Dr. Bhargava’s care. From infants with immune thrombocytopenia to teens with rare marrow disorders, his patient stories are filled with hope and healing.
“Our daughter was diagnosed with chronic ITP. After visiting multiple countries, we found Dr. Bhargava. Within weeks of treatment in India, her platelet count normalized, and she’s now thriving.” – Parent from Kenya.
Pediatric thrombocytopenia can be frightening for families, but with timely diagnosis and expert care, most children recover fully. India offers a holistic solution—afford. If you’re considering treatment for your child, reach out to Fortis Hospital Gurgaon and explore your options with confidence.